We Have Vaccines, Now What?

That is the title of my latest publication with co-authors Marlon Graf, Rifat Tuly, Christoph Glaetzer, Stacey Hickson, and Joey Mattingly. The subtitle is “How to Ensure Continued COVID-19 Vaccine Discovery and Expedite Access“. The abstract is below.

The coronavirus disease 2019 (COVID-19) pandemic has resulted in a catastrophic burden in both health and economic costs. Despite the December 2020 emergency use authorizations of two COVID-19 vaccines, there is still much work left to do. In this article, we assert that continued successful COVID-19 vaccine policies must have at least two components: (1) recognition of the value that COVID-19 vaccines bring to society; and (2) collaboration across stakeholders to ensure rapid population access and uptake. Implementing these approaches will facilitate the containment of COVID-19 while ensuring that innovators are able to sustain the discovery, development, and delivery of transformational medicines and vaccines, and—most importantly—improve the lives of billions of individuals around the world.

Read the whole article here.